苏桥生物（苏州）有限公司 CMAB Biopharma (Suzhou) Inc.
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
CMAB Biopharma Congratulates Partner Junshi Biosciences on NMPA Acceptance of Application for a Clinical Trial of its PD-1/TGF-β Bifunctional Fusion Protein 2021-03-08 11:41
CMAB Biopharma Congratulates Partner Innovent Biologics on FDA Clearance of IND Application of its COVID-19 Antibody Project 2021-03-03 11:12
CMAB Biopharma Congratulates QureBio on FDA Clearance of IND Application for Claudin18.2/PD-L1 Bispecific Antibody 2021-03-02 13:43
CMAB Biopharma and Laekna Therapeutics Enter Strategic Agreement for LAE005 Global Development and Commercialization Partnership 2020-09-10 20:08
CMAB Appoints Ms. Maggie Chen as Chief Financial Officer 2020-08-07 08:00
CMAB Biopharma's development and manufacturing platform successfully completes Q-1802 bispecific antibody project for QureBio within 9 months 2020-05-13 18:29
CMAB Biopharma Appoints Mr. Ye Shi as Head of Quality 2020-04-03 09:12
CMAB Biopharma Resumes Full-Scale Operation Following the Coronavirus Disease 2019 (COVID-19) Outbreak 2020-03-23 08:00
CMAB Biopharma and Fapon Biopharma Sign Agreement to Develop and Manufacture a Biologic Oncology Asset 2019-12-02 18:28
CMAB Biopharma and Fapon Biopharma Sign Agreement to Develop and Manufacture a Biologic Oncology Asset 2019-12-02 18:18
CMAB Biopharma and BJ Bioscience Establish an Exclusive Strategic Partnership 2019-10-11 18:00
CMAB Biopharma Receives Positive Opinion Following External Quality Audit 2019-09-05 18:41
CMAB and Kintor Announce a New Comprehensive Collaboration to Develop and Manufacture the ALK-1 Monoclonal Antibody 2019-08-21 21:35
CMAB Biopharma Announces Dr. Wang Yongzhong as CEO to Strengthen Leadership and Continue Business Expansion 2019-05-20 18:30
1